I’d Pay Very Close Attention to This if I Were a Marijuana Investor

Earlier this month, Aphria Inc. (TSX:APH) announced its plans to make a multi-million-dollar investment in a new state-of-the-art production facility outside its Leamington headquarters. Find out if this could mark a turning point for the rest of the cannabis industry.

On June 6, Aphria Inc. (TSX:APH), Canada’s third-largest medical marijuana company, announced that it plans to invest $55 million to build a brand new, state-of-the-art extraction facility.

In announcing the move, the company spun it as a social governance initiative: “We’re expanding our horizons in Leamington so that when our youth go away to school they’ve got something to come home to.”

And while there may be some truth to the company’s statement that the move is intended as a grassroots initiative to help provide skilled employment for local youth living near the company’s Leamington headquarters, the multi-million-dollar investment is far more about exploiting the apparent opportunities in marijuana extraction than anything else.

The planned facility will be capable of processing over 200,000 kilograms of marijuana plant annually, with the first deliveries expected towards the end of the first quarter in 2019.

Through advanced extraction methods involving the use of butane, ethanol, and CO2, the company aims to produce “world-class cannabis concentrates” that can then be converted into a myriads of applications from powders, creams, patches, edibles, and even infused beverages.

While it hasn’t received a tonne of attention in the mainstream press to date, those Fools fortunate to be blessed with shrewd memories may recall that Constellation Brands, Inc. (NYSE:STZ), one of the world’s largest alcoholic beverage makers, specifically touted the potential it saw in infused beverages last fall when it announced it was making a $245 million investment in Canopy Growth Corp. (TSX:WEED)(NYSE:CGC).

As Aphria’s chief financial officer Carl Merton said in announcing the company’s latest investment, the investment in extraction facilities sets the company up for “the wave after [this one] that no one even knows about yet.”

The proof is in the pudding…

Maybe the latest news shouldn’t come as such a surprise to those who have been following the evolution of Canada’s cannabis markets closely over the past few years.

As the market for product has matured, more sales for Canada’s licensed medical producers (recreational marijuana is still not legally available for sale) are coming from the sale of derivative products like oils, edibles and creams — rather than simply sales of the traditional marijuana flower.

Not only do oils and other derivative or extract products tend to carry with them higher margins for producers like Aphria (a good thing), they also promote several health benefits with them as compared to smoking the traditional flower through a cigarette or pipe.

A look to the future

As the values of licensed marijuana producers have soared in recent years, it only becomes more difficult for investors uncover the true “value” that remains hidden in the market.

One avenue worth considering is, of course, the implications for companies like Aphria, Canopy Growth, Cronos Group Inc. (TSX:CRON)(NASDAQ:CRON) and others to tap into the many international markets that continue to open.

But many are already looking at that opportunity square on — meaning that the next leg of the marijuana rally may actually end up coming from an advanced understanding of which manufacturers are able to lead the industry through innovation, including Aphria’s latest initiative.

Stay Foolish.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Jason Phillips owns shares in Aphria Inc.

More on Investing

how to save money
Investing

The Best TSX Stock for Canadians to Buy With $1,000 Right Now

iShares S&P/TSX 60 Index ETF (TSX:XIU) could be a great starter investment for new investors in Canada.

Read more »

Canadian dollars are printed
Dividend Stocks

Beat the TSX With This Cash-Gushing Dividend Stock

Toronto-Dominion Bank (TSX:TD) stock could do well in the year ahead.

Read more »

monthly desk calendar
Dividend Stocks

Monthly Income: Top Dividend Stocks to Buy in November

Here are two of the best monthly dividend stocks in Canada you can buy in November 2024 and hold for…

Read more »

hand stacks coins
Investing

A Top TSX Stock to Buy Now for Real Wealth Later

Intact Financial (TSX:IFC) stock is a fantastic dividend-growth play for the next 15 years and beyond.

Read more »

tsx today
Stock Market

TSX Today: What to Watch for in Stocks on Thursday, November 14

The U.S. wholesale inflation data and Fed chair Jerome Powell’s remarks about the economy will remain on TSX investors’ radar…

Read more »

Man data analyze
Tech Stocks

3 Reasons Celestica Stock Is a Screaming Buy Now

These three reasons make Celestica stock a screaming buy for long-term investors.

Read more »

profit rises over time
Dividend Stocks

These 2 Dow Stocks Are Set to Soar in 2025 and Beyond

Two Dow Jones stocks are screaming buys but Canadians must hold them in an RRSP or RRIF to avoid paying…

Read more »

TFSA (Tax free savings account) acronym on wooden cubes on the background of stacks of coins
Dividend Stocks

How to Use Your TFSA to Earn Ultimate Passive Income

If you have a TFSA, then you have the key to creating ultimate passive income. All you need is a…

Read more »